FDA approves first pill to prevent recurrent C. difficile infections聽
The Food and Drug Administration the first fecal microbiota product taken orally to prevent recurrent C. difficile infection.
鈥淭oday鈥檚 approval provides patients and healthcare providers a new way to help prevent recurrent C. difficile infection,鈥 Peter Marks, M.D., director of the FDA鈥檚 Center for Biologics Evaluation and Research. 鈥淭he availability of a fecal microbiota product that can be taken orally is a significant step forward in advancing patient care and accessibility for individuals who have experienced this disease that can be potentially life-threatening.鈥
Related News Articles
Headline
The Centers for Disease Control and Prevention and the Department of Health and Human Services adopted Aug. 4 the Advisory Committee on Immunization Practices鈥
Headline
Kindergarten vaccination rates declined during the 2024-25 school year, according to data released July 31 by the Centers for Disease Control and Prevention.鈥
Headline
The Department of Health and Human Services July 28 announced the creation of a $100 million pilot program to prevent, test for, treat and cure hepatitis C for鈥
Headline
Five pediatric flu deaths were reported to the Centers for Disease Control and Prevention last week, pushing the total to 266 for the 2024-2025 flu season,鈥
Headline
The Department of Health and Human Services July 23 announced it is recommending the removal of thimerosal from all U.S. flu vaccines. The announcement follows鈥
Headline
The Centers for Disease Control and Prevention July 7 announced it is streamlining H5N1 bird flu updates with its routine influenza data given the low public鈥